1st Quarter - Report

CAPITOL HILL CONSULTING GROUP for ELI LILLY AND COMPANY

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); FDA Globalization Act (H.R. 759); Follow-on Biologics; Comparative Effectiveness: Comparative Effectiveness Research Ace (S. 3408); Enhanced Health Care Value for All Act (H.R. 2184); Promoting Innovation and Access to Life-saving Medicine Act (H.R. 1427/S.726); Biologics Price Competition and Innovation Act (S.1695)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1427 (111th), S. 3408 (111th), S. 726 (111th), H.R. 2184 (111th), S. 1695 (111th), H.R. 759 (111th)

Medicare/Medicaid MMM

General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement.

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.